These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2467807)

  • 1. The late effects of cis-platinum on renal function.
    Hamilton CR; Bliss JM; Horwich A
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):185-9. PubMed ID: 2467807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.
    Dearnaley DP; Horwich A; A'Hern R; Nicholls J; Jay G; Hendry WF; Peckham MJ
    Eur J Cancer; 1991; 27(6):684-91. PubMed ID: 1712606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
    Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
    J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose bleomycin with etoposide and cisplatin for metastatic testicular teratoma.
    Coleman RE; Whillis D; Howard GC; Taylor RE; Cornbleet MA
    Br J Urol; 1991 Sep; 68(3):296-300. PubMed ID: 1717098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose cis-platinum combination chemotherapy in advanced nonseminomatous malignant germ cell tumours with emphasis on nephrotoxicity.
    Hall KS; Fosså SD; Aas M
    Cancer Chemother Pharmacol; 1986; 18(1):74-7. PubMed ID: 2428537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
    Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
    Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avascular necrosis in patients treated with BEP chemotherapy for testicular tumours.
    Coles C; Williams M
    Clin Oncol (R Coll Radiol); 2000; 12(1):69. PubMed ID: 10749025
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.
    Newell DR; Eeles RA; Gumbrell LA; Boxall FE; Horwich A; Calvert AH
    Cancer Chemother Pharmacol; 1989; 23(6):367-72. PubMed ID: 2469544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of platinum-induced renal toxicity on bleomycin-induced pulmonary toxicity in patients with disseminated testicular carcinoma.
    van Barneveld PW; Sleijfer DT; van der Mark TW; Mulder NH; Donker AJ; Meijer S; Schraffordt Koops H; Sluiter HJ; Peset R
    Oncology; 1984; 41(1):4-7. PubMed ID: 6199706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
    Horwich A; Dearnaley DP; Nicholls J; Jay G; Mason M; Harland S; Peckham MJ; Hendry WF
    J Clin Oncol; 1991 Jan; 9(1):62-9. PubMed ID: 1702147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumours. Appraisal of its potential as adjuvant chemotherapy for stage 1 testis tumours.
    Oliver RT; Dhaliwal HS; Hope-Stone HF; Blandy JP
    Br J Urol; 1988 Jan; 61(1):53-8. PubMed ID: 2449257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.
    Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G
    J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis.
    Horwich A; Peckham MJ
    Cancer Treat Rep; 1986 Nov; 70(11):1329-31. PubMed ID: 2429765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of adjuvant chemotherapy in testicular cancer.
    Bernstein JI; Freiha F; Breeden J; Torti FM
    Cancer; 1987 Oct; 60(8):1729-30. PubMed ID: 2443231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.